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Introduction
Inherited FVII deficiency is a rare autosomal recessive disorder. Its clinical presentation correlates poorly with FVII plasma levels. However, severe bleeding diathesis is observed when FVII activity is <1% (1). The gene encoding FVII (GENBANK:NM_000131) (2), spanning 12.8 kb of the q34 region on chromosome 13, is expressed only in hepatocytes.
IVS7 of this gene contains a minisatellite characterized by a 4-8 repeated 37-bp element (3).
The first repeat includes the last 4-bp of exon 7 and the first 33-bp of IVS7. Thus, the IVS7 repeated element provides multiple identical 5' splice-junctions, normally silent (3). Previous studies showed that other gene abnormalities (IVS7+5G>A, IVS7del3-7) weakened the IVS7 consensus sequence, leading to activation of the first downstream pseudo-site (4-5). We recently characterized two other mutations (IVS7+2T>G, R224Q) in the homozygous state in a child presenting with a lethal FVII deficiency (6). We investigated here the effects on the splicing of FVII transcripts of the IVS7+2T>G transversion, which abolishes the invariant GT-dinucleotide. The proband being deceased, transcripts were characterized through in vitro studies.
Study design
A FVII genomic region of 3.5kb, spanning intron 4 to exon 8 (nt7688-11188), was amplified from a normal individual and from the patient (forward primer Pa performed with 5µg of total RNA as a template, with random hexamers as primers (Pharmacia, Uppsala, Sweden) and Superscript II (Invitrogen). 1/10 of each of the first-strand synthesis reaction products was used in each of the three subsequent standard PCR reactions with oligonucleotides Pb (5'TCTGTGTGAACGAGAACGGC3') and Pm; Pe (5'AAGAAATGCCAGCAAACCCC3') and Pm; Ph (5'GGAGCTCAGTTGTGTGGGGG3') and Pm (Fig.1A) . Non-purified PCR products were cloned into the vector pTOPO-4 (Invitrogen). To characterize the aberrant transcripts, both strands of inserts were sequenced with the forward and reverse primers used for PCR.
Results and Discussion
The patient's phenotype (undetectable FVII plasma levels and lethal bleeding diathesis), combined with the IVS7 mutation, led us to investigate its effect on the FVII transcripts. Several lines of evidence suggest that the IVS7+2T>G transversion is the diseasecausing mutation. (i) It involves the GT invariant-dinucleotide, the alteration of which is known to impair normal splicing (7) (8) (9) (10) . (ii) This mutation that, according to our experiments, indeed impairs normal splicing, activates a cryptic site at IVS7+38 (Fig.1C ). This would lead to a 37-bp insertion between exons 7 and 8, resulting in a frameshift, with a premature termination codon at position 231. If synthesized, such a truncated protein would lack the catalytic domain. By contrast, the 10588G>A (R224Q) is likely to be a non disease-causing substitution: the R224 surface-residue is located in an evolutionary non-conserved region, moreover its conversion by alanine-scanning did not lead to activity or tissue factor binding decrease (11) . This mutation was found in the heterozygous state in an asymptomatic subject, in whom FVII levels (FVII:C 78%, FVII:Ag 94%) are consistent with a normal function (6).
Finally, this nucleotide substitution is located 12 nucleotides downstream to the premature termination-codon introduced by the 37-bp insertion. Different phenotypes were observed among patients carrying the other homozygous IVS7 mutations (4-5), although aberrantly spliced products were identical to those found in our study. This situation illustrates that mutations located in less-conserved nucleotides, unlike those involving invariant GT-dinucleotide, allow various amounts of normal splicing to occur (9), sufficient to prevent lethal bleeding diathesis.
To gain insight into the mechanism of splice site selection, the consensus values (CV) -which reflect the base-pairing stability between the U1 small nuclear (sn)RNA and a given
splice sequence (7)-of the GT-containing sequences in the surrounding region were calculated (Fig.2) . As expected, the authentic IVS7 5' splice site and each IVS7 pseudo-site have an identical CV. The IVS7+2T>G mutation results in a dramatic decrease of the CV of the IVS7 donor splice site to a value that is below that of several neighboring potential splice sites (Fig.2) . The CV of GT-containing sequence at IVS7+5 is slightly increased by the mutation (Fig.2) .
Several studies, reporting simultaneous activation of multiple cryptic sites upon a single 5'splice-site mutation (12) (13) (14) (15) , postulate that cryptic sites compete at different efficiencies for activation, according to their ability to bind U1snRNA (12) (13) (14) . This is especially observed when a mutation within the authentic site decreases its affinity for U1snRNA to the same approximate level to that of putative cryptic sites (16) . In one case (LPL gene), the use, at low efficiency, of a highly-homologous pseudo-site was even demonstrated in the normal allele (12) . In the present case, the mutant FVII pre-mRNA contains multiple potential cryptic sites of strengths higher than that of the mutated authentic site. According to the above-mentioned studies, these sites could be competitively activated at different efficiencies, with a higher degree of activation for each IVS7 5' pseudo-site (16) . Strikingly, only the most upstream of the IVS7 5' pseudo-sites, located in the second IVS7 minisatellite repeat, is activated. No exon skipping was observed despite the high strength of the donor site of the preceding intron (IVS6) (Fig.2) .
Taken together, these data strongly suggest the existence, in the IVS7-FVII gene, of a specific physiological mechanism that selects the most upstream 5' splice site, like that discussed for G-triplets (17, 18) . In our case, the possible repression of the 3' following pseudo-site(s) is another hypothesis that could account for this situation; however this possibility was rejected, since the mutation of the authentic 5' splice site was shown to result in the activation of the following 5' pseudo-site. This model also accounts for the absence of For The statistical rules of Shapiro and Senopathy were applied to assign a consensus value expressed in percentage of homology to the consensus sequence (7) . A score of 100 represents the best match, 0 represents the worst one. The CV of the IVS6 donor site and the authentic and mutated IVS7 donor splice site were rated according to this procedure, and potential cryptic sites along exon 7 and in each 37 bp element of the IVS7 minisatellite were researched 
